Product
ALN-TTRSC
1 clinical trial
1 indication
Indication
TTR-mediated AmyloidosisClinical trial
A Phase 2, Open-Label Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Exploratory Clinical Activity of ALN-TTRSC in Patients With Transthyretin (TTR) Cardiac AmyloidosisStatus: Completed, Estimated PCD: 2014-10-01